Calyxt, Inc. Stock Nasdaq
Stocks
CBUS
US17166A1016
Advanced Medical Equipment & Technology
| Market Cap | 93.89M 81.09M 74.73M 69.95M 131M 8.92B 133M 882M 344M 4.34B 352M 345M 15.04B | P/E Ratio 2026 * |
-1.34x | P/E Ratio 2027 * | -1.41x |
|---|---|---|---|---|---|
| Enterprise Value | 93.89M 81.09M 74.73M 69.95M 131M 8.92B 133M 882M 344M 4.34B 352M 345M 15.04B | EV / Sales 2026 * |
12.1x | EV / Sales 2027 * | 6.8x |
| Free-Float |
74.82% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Calyxt, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Craig Wichner
CEO | Chief Executive Officer | 57 | 2026-06-07 |
Greg Gocal
CTO | Chief Tech/Sci/R&D Officer | 57 | 2013-12-31 |
Peter Beetham
CEO | Chief Executive Officer | 63 | 2025-02-23 |
| Director | Title | Age | Since |
|---|---|---|---|
Rory Riggs
CHM | Chairman | 72 | 2000-12-31 |
Mark Finn
CHM | Chairman | 82 | 2025-08-05 |
| Director/Board Member | 87 | 2009-10-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 93.83M | |
| -1.33% | -0.73% | +16.53% | -10.78% | 174B | |
| -0.45% | -2.61% | -19.74% | +30.31% | 146B | |
| -0.38% | -2.28% | -10.25% | -25.35% | 127B | |
| -0.55% | -3.38% | -52.97% | -8.31% | 69.72B | |
| -0.76% | -0.99% | +13.25% | -2.62% | 49.01B | |
| +0.67% | -0.60% | -24.14% | -34.78% | 44.74B | |
| +0.22% | -4.13% | +10.90% | +8.65% | 36.67B | |
| -1.17% | -2.69% | +3.87% | +35.04% | 34.91B | |
| +1.04% | +0.79% | -9.79% | -16.21% | 29.65B | |
| Average | -0.27% | -2.10% | -8.04% | -2.67% | 79.13B | |
| Weighted average by Cap. | -0.55% | -1.98% | -7.27% | -2.67% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.78M 6.72M 6.19M 5.8M 10.86M 739M 11.03M 73.11M 28.5M 360M 29.2M 28.57M 1.25B | 13.81M 11.93M 10.99M 10.29M 19.29M 1.31B 19.59M 130M 50.62M 639M 51.84M 50.74M 2.21B |
| Net income | -62.16M -53.69M -49.47M -46.31M -86.78M -5.91B -88.13M -584M -228M -2.88B -233M -228M -9.96B | -67.22M -58.06M -53.5M -50.08M -93.85M -6.39B -95.3M -632M -246M -3.11B -252M -247M -10.77B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
